BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18604982)

  • 21. DNAzyme technology and cancer therapy: cleave and let die.
    Dass CR; Choong PF; Khachigian LM
    Mol Cancer Ther; 2008 Feb; 7(2):243-51. PubMed ID: 18281510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
    Zhou DX; Liang QS; He XX; Zhan CY
    Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(8):936-9. PubMed ID: 18619357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immediate early genes, c-fos, c-jun and AP-1, are early markers of platinum analogue toxicity in human proximal tubular cell primary cultures.
    Wainford RD; Weaver RJ; Hawksworth GM
    Toxicol In Vitro; 2009 Aug; 23(5):780-8. PubMed ID: 19383537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resurrecting DNAzymes as sequence-specific therapeutics.
    Rossi JJ
    Sci Transl Med; 2012 Jun; 4(139):139fs20. PubMed ID: 22723461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNAzyme delivery systems: getting past first base.
    Tan ML; Choong PF; Dass CR
    Expert Opin Drug Deliv; 2009 Feb; 6(2):127-38. PubMed ID: 19239385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly active low magnesium hammerhead ribozyme.
    Fedoruk-Wyszomirska A; Szymański M; Wyszko E; Barciszewska MZ; Barciszewski J
    J Biochem; 2009 Apr; 145(4):451-9. PubMed ID: 19124457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cleavage of HPV-16 E6/E7 mRNA mediated by modified 10-23 deoxyribozymes.
    Reyes-Gutiérrez P; Alvarez-Salas LM
    Oligonucleotides; 2009 Sep; 19(3):233-42. PubMed ID: 19732021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo study on the effects of microcystin extracts on the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of male Wistar rats injected i.v. with toxins.
    Li H; Xie P; Li G; Hao L; Xiong Q
    Toxicon; 2009 Jan; 53(1):169-75. PubMed ID: 19041662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Jun N-terminal kinase pathways in diabetes.
    Yang R; Trevillyan JM
    Int J Biochem Cell Biol; 2008; 40(12):2702-6. PubMed ID: 18678273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A DNAzyme cascade for the amplified detection of Pb(2+) ions or L-histidine.
    Elbaz J; Shlyahovsky B; Willner I
    Chem Commun (Camb); 2008 Apr; (13):1569-71. PubMed ID: 18354802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-Specific Bioorthogonal Activation of DNAzymes for On-Demand Gene Therapy.
    Wang R; He W; Yi X; Wu Z; Chu X; Jiang JH
    J Am Chem Soc; 2023 Aug; 145(32):17926-17935. PubMed ID: 37535859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of JUN in the regulation of PRKCC-mediated STAR expression and steroidogenesis in mouse Leydig cells.
    Manna PR; Stocco DM
    J Mol Endocrinol; 2008 Nov; 41(5):329-41. PubMed ID: 18755854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribozymes, DNAzymes and small interfering RNAs as therapeutics.
    Sioud M; Iversen PO
    Curr Drug Targets; 2005 Sep; 6(6):647-53. PubMed ID: 16178798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A DNAzyme with three protein-like functional groups: enhancing catalytic efficiency of M2+-independent RNA cleavage.
    Hollenstein M; Hipolito CJ; Lam CH; Perrin DM
    Chembiochem; 2009 Aug; 10(12):1988-92. PubMed ID: 19591189
    [No Abstract]   [Full Text] [Related]  

  • 35. Allergen Responses Modified by a GATA3 DNAzyme.
    Caramori G; Chung KF; Barnes PJ
    N Engl J Med; 2015 Sep; 373(12):1176-7. PubMed ID: 26376148
    [No Abstract]   [Full Text] [Related]  

  • 36. Allergen Responses Modified by a GATA3 DNAzyme.
    Buhl R; Garn H; Renz H
    N Engl J Med; 2015 Sep; 373(12):1177. PubMed ID: 26376147
    [No Abstract]   [Full Text] [Related]  

  • 37. Probing metal binding in the 8-17 DNAzyme by TbIII luminescence spectroscopy.
    Kim HK; Li J; Nagraj N; Lu Y
    Chemistry; 2008; 14(28):8696-703. PubMed ID: 18688837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multifunctional DNA nano-scorpion for highly efficient targeted delivery of mRNA therapeutics.
    Li D; Mo F; Wu J; Huang Y; Zhou H; Ding S; Chen W
    Sci Rep; 2018 Jul; 8(1):10196. PubMed ID: 29976947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translational regulation mechanisms of AP-1 proteins.
    Vesely PW; Staber PB; Hoefler G; Kenner L
    Mutat Res; 2009; 682(1):7-12. PubMed ID: 19167516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of a DNAzyme : Prediction of mRNA Regions Accessible to a DNAzyme.
    Steger G; Victor J
    Methods Mol Biol; 2022; 2439():47-63. PubMed ID: 35226314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.